Open AccessA phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome
Author(s) -
Rami S. Komrokji,
Hetty E. Carraway,
Ulrich Germing,
Martin Wermke,
Amer M. Zeidan,
Eric Fu,
Björn Rüter,
Ute Burkard,
Annika Osswald,
James M. Foran
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.280500
Subject(s) - medicine , myelodysplastic syndromes , open label , oncology , randomized controlled trial , bone marrow